Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_assertion type Assertion NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_head.
- NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_assertion description "[We used ALK fusion-positive and -negative lung cancer cell lines; crizotinib, PHA-665752, and saracatinib, and stable transfection with shMET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_provenance.
- NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_assertion evidence source_evidence_literature NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_provenance.
- NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_assertion SIO_000772 24490607 NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_provenance.
- NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_assertion wasDerivedFrom befree-20150227 NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_provenance.
- NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_assertion wasGeneratedBy ECO_0000203 NP235632.RAw_d5uVJGVHSjeQZ-xSe0CAV5muxyM6B78imVPfdxRgY130_provenance.